Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes

Graphical abstract

• Publication year

  2021

• Venue

  Current Research in Toxicology

• Publication date

  2021-08-17

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.crtox.2021.08.003PMID 34485931PMCID 8408431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The in vitro ToxTracker and Aneugen Clastogen Evaluation extension assay as a tool in the assessment of relative genotoxic potential of e-liquids and their aerosols

  2021cited by this paper
• The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes

  2020cited by this paper
• In vitro biological assessment of the stability of cigarette smoke aqueous aerosol extracts

  2020cited by this paper
• Collecting e‐cigarette aerosols for in vitro applications: A survey of the biomedical literature and opportunities to increase the value of submerged cell culture‐based assessments

  2020influential reference
• Mainstream smoke constituents and in vitro toxicity comparative analysis of 3R4F and 1R6F reference cigarettes

  2019cited by this paper
• Human Cell-Based in vitro Phenotypic Profiling for Drug Safety-Related Attrition

  2019cited by this paper
• A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers

  2019cited by this paper
• Toxicological comparison of cigarette smoke and e‐cigarette aerosol using a 3D in vitro human respiratory model

  2019cited by this paper
• The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy

  2019cited by this paper
• WHO Report on the Global Tobacco Epidemic, 2019

  2019cited by this paper
• Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system.

  2019cited by this paper
• Chemical Analysis and Simulated Pyrolysis of Tobacco Heating System 2.2 Compared to Conventional Cigarettes

  2019cited by this paper
• A New Venue of TNF Targeting

  2018cited by this paper
• Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real‐life setting

  2018cited by this paper
• Determination of eight carbonyl compounds in aerosols trapped in phosphate buffer saline solutions to support in vitro assessment studies.

  2018cited by this paper
• Characterization of a Vitrocell VC1 Using Nicotine Dosimetry: An Essential Component Toward Standardized In Vitro Aerosol Exposure of Tobacco and Next Generation Nicotine Delivery Products

  2018cited by this paper
• AB0050 Biomap® phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity

  2018cited by this paper
• Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

  2018cited by this paper
• Accurate measurement of main aerosol constituents from heated tobacco products (HTPs): Implications for a fundamentally different aerosol

  2018cited by this paper
• Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators.

  2017influential reference
• Investigation of solid particles in the mainstream aerosol of the Tobacco Heating System THS2.2 and mainstream smoke of a 3R4F reference cigarette

  2017cited by this paper
• Phenotypic chemical biology for predicting safety and efficacy.

  2017cited by this paper
• Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers

  2017cited by this paper
• Nicotine Quantification In Vitro: A Consistent Dosimetry Marker for e-Cigarette Aerosol and Cigarette Smoke Generation

  2017cited by this paper
• Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked

  2017cited by this paper
• HEALTH IMPACT OF E‐CIGARETTES: A PROSPECTIVE 3.5‐YEAR STUDY OF REGULAR USERS WHO HAVE NEVER SMOKED

  2017cited by this paper
• Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?

  2016cited by this paper
• Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells.

  2016cited by this paper
• E-cigarettes and the need and opportunities for alternatives to animal testing.

  2016cited by this paper
• Evaluation of E-Cigarette Liquid Vapor and Mainstream Cigarette Smoke after Direct Exposure of Primary Human Bronchial Epithelial Cells

  2015cited by this paper
• Elucidating Mechanisms of Toxicity Using Phenotypic Data from Primary Human Cell Systems—A Chemical Biology Approach for Thrombosis-Related Side Effects

  2015cited by this paper
• A Systems Biology Approach Reveals the Dose- and Time-Dependent Effect of Primary Human Airway Epithelium Tissue Culture After Exposure to Cigarette Smoke In Vitro

  2015cited by this paper
• Smoking is associated with combined allergic and irritant hand eczema, contact allergies and hyperhidrosis

  2015cited by this paper
• E-cigarettes: an evidence update. A report commissioned by Public Health England.

  2015cited by this paper
• Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface

  2015cited by this paper
• Comparative In Vitro Toxicity Profile of Electronic and Tobacco Cigarettes, Smokeless Tobacco and Nicotine Replacement Therapy Products: E-Liquids, Extracts and Collected Aerosols

  2014cited by this paper
• Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms

  2014cited by this paper
• Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation

  2014cited by this paper
• The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.

  2014cited by this paper
• Comparison of the Cytotoxic Potential of Cigarette Smoke and Electronic Cigarette Vapour Extract on Cultured Myocardial Cells

  2013cited by this paper
• Building Predictive Models for Mechanism-of-Action Classification from Phenotypic Assay Data Sets

  2013cited by this paper
• Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation

  2013cited by this paper
• Levels of selected carcinogens and toxicants in vapour from electronic cigarettes

  2013cited by this paper
• Reducing harm from tobacco use

  2013cited by this paper
• Systems biology approach reveals a dose-dependent recovery of primary human airway epithelium culture after exposure to cigarette smoke

  2013cited by this paper
• Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors

  2012cited by this paper
• A lung dosimetry model of vapor uptake and tissue disposition

  2012cited by this paper
• The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis

  2011cited by this paper
• Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.

  2011cited by this paper
• Effects of tobacco smoke on immunity, inflammation and autoimmunity.

  2010cited by this paper
• Chemical target and pathway toxicity mechanisms defined in primary human cell systems.

  2010cited by this paper
• Toxicity Testing in the 21st Century: A Vision and a Strategy

  2010cited by this paper
• Nicotine chemistry, metabolism, kinetics and biomarkers.

  2009cited by this paper
• Exposure as Part of a Systems Approach for Assessing Risk

  2009cited by this paper
• Profiling Bioactivity of the ToxCast Chemical Library Using BioMAP Primary Human Cell Systems

  2009cited by this paper
• Evaluation of In vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco

  2009cited by this paper
• The Aryl Hydrocarbon Receptor Attenuates Tobacco Smoke-induced Cyclooxygenase-2 and Prostaglandin Production in Lung Fibroblasts through Regulation of the NF-κB Family Member RelB*

  2008cited by this paper
• The Chemical Components of Tobacco and Tobacco Smoke

  2008cited by this paper
• Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.

  2008cited by this paper
• The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease.

  2005cited by this paper
• The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts.

  2005cited by this paper
• Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse

  2004cited by this paper
• Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse.

  2004cited by this paper
• Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker.

  2002cited by this paper
• The Nicotine Inhaler

  2001cited by this paper
• Cell number and distribution in human and rat airways.

  1994cited by this paper
• The normal human lung: ultrastructure and morphometric estimation of diffusion capacity.

  1978cited by this paper
• Vapour products - Routine analytical vaping machine - Definitions and standard conditions

  year unknowncited by this paper

• Integration of New Approach Methods for the Assessment of Data Poor Chemicals.

  2025cites this paper
• E-Cigarette and Endothelial Function─A Critical Review of Preclinical Studies.

  2025cites this paper
• Countdown to 2027 - maximising use of NAMs in food safety assessment: closing the gap for regulatory assessments in Europe.

  2025cites this paper
• The Product Science of Electrically Heated Tobacco Products: An Updated Narrative Review of the Scientific Literature

  2024cites this paper
• Impact of a varied set of stimuli on a suite of immunological parameters within peripheral blood mononuclear cells: toward a non-animal approach for assessing immune modulation by materials intended for human use

  2024cites this paper
• Applying new approach methodologies to assess next-generation tobacco and nicotine products

  2024cites this paper
• Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke

  2023cites this paper
• Preclinical Assessment of Tobacco-Free Nicotine Pouches Demonstrates Reduced In Vitro Toxicity Compared with Tobacco Snus and Combustible Cigarette Smoke

  2022cites this paper
• Evaluation of 147 Perfluoroalkyl Substances for Immunotoxic and Other (Patho)physiological Activities through Phenotypic Screening of Human Primary Cells

  2022cites this paper
• Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products

  2022cites this paper